Ipsen
(OTC) IPSEF
Ipsen Financials at a Glance
Market Cap
$9.36B
Revenue (TTM)
$7.25B
Net Income (TTM)
$848.81M
EPS (TTM)
$5.91
P/E Ratio
19.00
Dividend
$1.60
Beta (Volatility)
-0.02 (Low)
Dividend
$1.60
Beta (Volatility)
-0.02 (Low)
Price
$113.13
Volume
10
Open
$113.13
Price
$113.13
Volume
10
Open
$113.13
Previous Close
$113.13
Daily Range
$113.13 - $113.13
52-Week Range
$103.50 - $113.13
Dividend
$1.60
Beta (Volatility)
-0.02 (Low)
Price
$113.13
Volume
10
Open
$113.13
Previous Close
$113.13
Daily Range
$113.13 - $113.13
52-Week Range
$103.50 - $113.13
IPSEF News
IPSEF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ipsen
Industry
Pharmaceuticals
Sector
Health CareEmployees
5,535
CEO
David G. Loew, MBA
Website
www.ipsen.comHeadquarters
Boulogne-Billancourt, 92100, FR
IPSEF Financials
Key Financial Metrics (TTM)
Gross Margin
71%
Operating Margin
20%
Net Income Margin
12%
Return on Equity
10%
Return on Capital
14%
Return on Assets
6%
Earnings Yield
5.26%
Dividend Yield
0.01%
Payout Ratio
26.20%
Stock Overview
Market Cap
$9.36B
Shares Outstanding
82.71M
Volume
10
Short Interest
0.00%
Avg. Volume
8.387
Financials (TTM)
Gross Profit
$2.59B
Operating Income
$746.02M
EBITDA
$1.10B
Operating Cash Flow
$1.14B
Capital Expenditure
$105.26M
Free Cash Flow
$1.03B
Cash & ST Invst.
$1.52B
Total Debt
$1.05B
Ipsen Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.53B
-3.8%
Gross Profit
$832.89M
-35.4%
Gross Margin
54.41%
N/A
Market Cap
$9.36B
N/A
Market Cap/Employee
$1.75M
N/A
Employees
5,358
N/A
Net Income
$109.46M
-75.6%
EBITDA
$351.81M
-47.6%
Quarterly Fundamentals
Net Cash
$471.22M
+619.4%
Accounts Receivable
$931.75M
+47.6%
Inventory
$256.50M
-11.4%
Long Term Debt
$917.46M
+240.2%
Short Term Debt
$136.25M
+12.1%
Return on Assets
6.39%
N/A
Return on Invested Capital
13.57%
N/A
Free Cash Flow
$561.49M
+76.2%
Operating Cash Flow
$611.47M
+42.7%